Publications by authors named "Jason Westin"

100Publications

Why R-CHOP + X is not enough: lessons learned and next steps in the mission to improve frontline therapy for diffuse large B-cell lymphoma.

Leuk Lymphoma 2021 Jan 6:1-17. Epub 2021 Jan 6.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF
January 2021

ICU Resource Use in Critically III Patients following Chimeric Antigen Receptor T-Cell Therapy.

Am J Respir Crit Care Med 2020 10;202(8):1184-1187

The University of Texas MD Anderson Cancer Center Houston, Texas.

View Article and Find Full Text PDF
October 2020

CAR T-Cells.

Adv Exp Med Biol 2020 ;1244:215-233

Department of Lymphoma and Myeloma, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF
July 2020

Ibrutinib and lenalidomide: when 1+1 = >2.

Authors:
Jason Westin

Blood 2019 09;134(13):996-998

MD Anderson Cancer Center.

View Article and Find Full Text PDF
September 2019

Rosai-Dorfman Disease: The MD Anderson Cancer Center Experience.

Clin Lymphoma Myeloma Leuk 2019 11 4;19(11):709-714. Epub 2019 Jul 4.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article and Find Full Text PDF
November 2019

Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction.

Cell 2019 07 4;178(3):699-713.e19. Epub 2019 Jul 4.

Division of Oncology, Department of Medicine, Stanford University, Stanford, CA, USA; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA; Stanford Cancer Institute, Stanford University, Stanford, CA, USA. Electronic address:

View Article and Find Full Text PDF
July 2019

A rare case of methotrexate and primaquine co-administration in a mantle cell lymphoma patient.

J Clin Pharm Ther 2019 Oct 20;44(5):800-804. Epub 2019 May 20.

Department of Pharmacy Clinical Services, The University of Texas M.D. Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF
October 2019

The Other Side of CAR T-Cell Therapy: Cytokine Release Syndrome, Neurologic Toxicity, and Financial Burden.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:433-444. Epub 2019 May 17.

3 The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article and Find Full Text PDF
January 2019

Reply to J. Wang et al.

J Clin Oncol 2019 03 12;37(9):755-757. Epub 2019 Feb 12.

David M. Kurtz, MD, PhD; Florian Scherer, MD; Michael C. Jin; Joanne Soo; Alexander F.M. Craig, MPhil; Mohammad S. Esfahani, PhD; Jacob J. Chabon, PhD; Henning Stehr, PhD; Chih Long Liu, PhD; Robert Tibshirani, PhD; Lauren S. Maeda, MD; Neel K. Gupta, MD; Michael S. Khodadoust, MD, PhD; Ranjana H. Advani, MD; and Aaron M. Newman, PhD, Stanford University, Stanford, CA; Ulrich Dührsen, MD; and Andreas Hüttmann, MD, University Hospital Essen, Essen, Germany; Michel Meignan, MD, PhD, Hôpitaux Universitaires Henri Mondor, Creteil, France; Olivier Casasnovas, MD, Centre Hospitalier Universitaire, Dijon, France; Jason R. Westin, MD, The University of Texas MD Anderson Cancer Center, Houston, TX; Mark Roschewski, MD; and Wyndham H. Wilson, MD, PhD, National Institutes of Health, Bethesda, MD; Gianluca Gaidano, MD, PhD; and Davide Rossi, MD, PhD, University of Eastern Piedmont, Novara, Italy, Oncology Institute of Southern Switzerland and Institute of Oncology Research, Bellinzona, Switzerland; and Maximilian Diehn, MD, PhD; and Ash A. Alizadeh, MD, PhD, Stanford University, Stanford, CA.

View Article and Find Full Text PDF
March 2019

Emerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue.

Clin Lymphoma Myeloma Leuk 2019 04 3;19(4):244-250. Epub 2019 Jan 3.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article and Find Full Text PDF
April 2019

Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival ?

Ann Hematol 2019 May 8;98(5):1169-1176. Epub 2019 Jan 8.

Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.

View Article and Find Full Text PDF
May 2019

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

N Engl J Med 2019 01 1;380(1):45-56. Epub 2018 Dec 1.

From the Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia (S.J.S.); the Hematopoietic Cellular Therapy Program, University of Chicago Medicine, Chicago (M.R.B.); Peter MacCallum Cancer Centre, St. Vincent's Hospital and University of Melbourne, Melbourne, VIC (C.S.T.), and the Royal Prince Alfred Hospital and Department of Medicine, University of Sydney, Sydney (P.J.H.) - both in Australia; Winship Cancer Institute of Emory University, Bone Marrow and Stem Cell Transplant Center, Atlanta (E.K.W.); the Department of Hematology and Oncology, University Hospital of Cologne, Cologne (P.B.), and the Würzburg University Medical Center, Center for Allogeneic Stem Cell Transplantation, Würzburg (S.M.) - both in Germany; the Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Cancer Center, Kansas City (J.P.M.); the Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna (U.J.); James Cancer Hospital and Solove Research Institute, Ohio State University Comprehensive Cancer Center, Columbus (S.J.); the Department of Hematology and Blood and Marrow Transplant, University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco (C.A.); the Department of Lymphoma and Myeloma, Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center, Houston (J.R.W.); Maisonneuve-Rosemont Hospital, University of Montreal, Montreal (I.F.), and the Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, ON (S.R.F.) - both in Canada; the Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis (V.B.); Karolinska Institutet and University Hospital, Department of Laboratory Medicine/Department of Cell Therapy and Allogeneic Stem Cell Transplantation, Stockholm (S.M.); University of Michigan Comprehensive Cancer Center, Ann Arbor (J.M.M.); the Department of Oncology, Oslo University Hospital, Oslo (H.H.); Novartis Pharma, Basel, Switzerland (S.P., O.A.); Novartis Pharmaceuticals (L.B.P., J.C.) and Novartis Institutes for BioMedical Research (R.A.), East Hanover, NJ; the Department of Hematology, Hospices Civils de Lyon, Université de Lyon, Lyon, France (G.S.); and the Center for Hematologic Malignancies, Oregon Health and Science University Knight Cancer Institute, Portland (R.T.M.).

View Article and Find Full Text PDF
January 2019

Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma.

J Clin Oncol 2018 10 20;36(28):2845-2853. Epub 2018 Aug 20.

David M. Kurtz, Florian Scherer, Michael C. Jin, Joanne Soo, Alexander F.M. Craig, Mohammad Shahrokh Esfahani, Jacob J. Chabon, Henning Stehr, Chih Long Liu, Robert Tibshirani, Lauren S. Maeda, Neel K. Gupta, Michael S. Khodadoust, Ranjana H. Advani, Ronald Levy, Aaron M. Newman, Maximilian Diehn, and Ash A. Alizadeh, Stanford University, Stanford, CA; Florian Scherer, University Medical Center Freiburg, Freiburg; Ulrich Dührsen and Andreas Hüttmann, University Hospital Essen, Essen, Germany; Michel Meignan, Hôpitaux Universitaires Henri Mondor, Creteil; René-Olivier Casasnovas, Hôpital Le Bocage, Centre Hospitalier Universitaire, Dijon, France; Jason R. Westin, University of Texas MD Anderson Cancer Center, Houston, TX; Mark Roschewski and Wyndham H. Wilson, National Cancer Institute, National Institutes of Health, Bethesda, MD; Gianluca Gaidano and Davide Rossi, University of Eastern Piedmont, Novara, Italy; and Davide Rossi, Oncology Institute of Southern Switzerland and Institute of Oncology Research, Bellinzona, Switzerland.

View Article and Find Full Text PDF
October 2018

Primary breast diffuse large B-cell lymphoma: treatment strategies and patterns of failure.

Leuk Lymphoma 2018 12 26;59(12):2896-2903. Epub 2018 Apr 26.

b Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article and Find Full Text PDF
December 2018

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

N Engl J Med 2017 12 10;377(26):2531-2544. Epub 2017 Dec 10.

From the University of Texas M.D. Anderson Cancer Center, Houston (S.S.N., J.R.W.); H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL (F.L.L., J.C.C.); Washington University and Siteman Cancer Center, St. Louis (N.L.B., A. Ghobadi); University of Miami, Miami (L.J.L., K.V.K.); Stanford University, Stanford (D.B.M., R.L.), City of Hope National Medical Center, Duarte (T.S.), University of California at Los Angeles, Los Angeles (J.M.T.), University of California at San Diego, San Diego (J.E.C.), and Kite Pharma, Santa Monica (A.B., J.R., L.N., Y.J., J.A., M.E., D.C., J.W., W.Y.G.) - all in California; Dana-Farber Cancer Institute, Boston (C.A.J., E.D.J.); Montefiore Medical Center, Bronx (I.B.), and the University of Rochester School of Medicine, Rochester (J.W.F., P.R.) - both in New York; Vanderbilt University Medical Center (O.O.O.) and the Sarah Cannon Research Institute and Tennessee Oncology (I.W.F.), Nashville; Mayo Clinic, Rochester, MN (Y.L., T.E.W.); Loyola University Medical Center, Maywood, IL (P.J.S.); John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ (A. Goy); Cleveland Clinic, Cleveland (B.T.H., M.R.S.); Karmanos Cancer Center, Wayne State University, Detroit (A.D.); University of Iowa Carver College of Medicine, Iowa City (U.F.); Colorado Blood Cancer Institute, Denver (P.M.S.); Banner M.D. Anderson Cancer Center, Gilbert, AZ (J.M.); and Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (I.A.).

View Article and Find Full Text PDF
December 2017

Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOP.

Clin Lymphoma Myeloma Leuk 2018 01 14;18(1):e103-e108. Epub 2017 Nov 14.

Department of Lymphoma and Myeloma, The University of Texas, M.D. Anderson Cancer Center, Houston, TX. Electronic address:

View Article and Find Full Text PDF
January 2018

Chimeric antigen receptor T-cell therapy - assessment and management of toxicities.

Nat Rev Clin Oncol 2018 Jan 19;15(1):47-62. Epub 2017 Sep 19.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

View Article and Find Full Text PDF
January 2018

Primary Bone Lymphoma Exhibits a Favorable Prognosis and Distinct Gene Expression Signatures Resembling Diffuse Large B-Cell Lymphoma Derived From Centrocytes in the Germinal Center.

Am J Surg Pathol 2017 Oct;41(10):1309-1321

*Department of Oncology, The First Affiliated Hospital Zhengzhou University, Zhengzhou, China Departments of †Hematopathology ‡Radiation Oncology §Bioinformatics and Computational Biology ∥Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center #Graduate School of Biomedical Sciences, The University of Texas Health Science Center, Houston, TX ¶Department of Pathology, Harvard University Medical School, Boston, MA.

View Article and Find Full Text PDF
October 2017

Dose-Adjusted EPOCH-R and Mid-Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement.

Br J Haematol 2017 12 9;179(5):851-854. Epub 2016 Aug 9.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF
December 2017

What to Do With Success? The Optimist's Creed in Relapsed Hodgkin Lymphoma.

Clin Lymphoma Myeloma Leuk 2016 09 8;16(9):483-487. Epub 2016 Jun 8.

Division of Cancer Medicine, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article and Find Full Text PDF
September 2016

Deeper Insights Into Vanishing Bile Duct Syndrome in Lymphoma: A Perplexing Entity.

Clin Lymphoma Myeloma Leuk 2016 05 27;16(5):e65-70. Epub 2016 Feb 27.

Division of Cancer Medicine, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article and Find Full Text PDF
May 2016

Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin lymphoma.

Haematologica 2015 Jul 27;100(7):e272-4. Epub 2015 Mar 27.

Department of Lymphoma and Myeloma, University of Texas, MD Anderson Cancer Center, Houston, TX 77030 USA.

View Article and Find Full Text PDF
July 2015

Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma.

Int J Radiat Oncol Biol Phys 2015 May 5;92(1):122-9. Epub 2015 Mar 5.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article and Find Full Text PDF
May 2015

Multimodality imaging of Epstein-Barr virus-associated inflammatory pseudotumor-like follicular dendritic cell tumor of the spleen: case report and literature review.

Clin Imaging 2015 May-Jun;39(3):525-8. Epub 2015 Jan 7.

Department of Diagnostic Radiology, Unit 1473, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030-4009. Electronic address:

View Article and Find Full Text PDF
November 2015

A clinician's guide to double hit lymphomas.

Br J Haematol 2015 Mar 22;168(6):784-95. Epub 2014 Dec 22.

Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF
March 2015

Busting robustness: using cancer's greatest strength to our advantage.

Authors:
Jason R Westin

Future Oncol 2015 ;11(1):73-7

1400 Holcombe Blvd, Unit 0429, Houston, TX 77030, USA.

View Article and Find Full Text PDF
September 2015

Status of PI3K/Akt/mTOR pathway inhibitors in lymphoma.

Authors:
Jason R Westin

Clin Lymphoma Myeloma Leuk 2014 Oct 7;14(5):335-42. Epub 2014 Feb 7.

Division of Cancer Medicine, Department of Lymphoma and Myeloma, University of Texas M.D. Anderson Cancer Center, Houston, TX. Electronic address:

View Article and Find Full Text PDF
October 2014

Accelerated therapeutic progress in diffuse large B cell lymphoma.

Ann Hematol 2014 Apr 28;93(4):541-56. Epub 2013 Dec 28.

Department of Medical Oncology, Cancer Center, Sun Yat-sen University, Guangzhou, China.

View Article and Find Full Text PDF
April 2014